本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Immunome Inc.

29.67
+1.665.93%
成交量:60.17萬
成交額:1,768.86萬
市值:33.70億
市盈率:-11.94
高:29.72
開:28.06
低:28.06
收:28.01
52周最高:30.06
52周最低:8.67
股本:1.14億
流通股本:1.08億
量比:0.67
換手率:0.56%
股息:- -
股息率:- -
每股收益(TTM):-2.4851
每股收益(LYR):-2.4315
淨資產收益率:-64.03%
總資產收益率:-37.78%
市淨率:6.42
市盈率(LYR):-12.20

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]